Infectious Diseases News and Research

RSS

Science names HIV prevention trial as '2011 Breakthrough of the Year'

"The journal Science has chosen the HPTN 052 clinical trial, an international HIV prevention trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID)," which found that early treatment with antiretroviral drugs (ARVs) reduced the risk of transmission among sero-discordant partners by 96 percent, as the "2011 Breakthrough of the Year," an NIH press release states (12/22).

23 Dec 2011

Injected meth users at greater risk of attempting suicide

The dire physical and mental health effects of injecting methamphetamine are well known, but there's been little research about suicidal behavior and injecting meth.

23 Dec 2011

Anti-cancer drugs may also fight antibiotic resistance

Drugs used to overcome cancer may also combat antibiotic resistance, finds a new study led by Gerry Wright, scientific director of the Michael G. DeGroote Institute for Infectious Disease Research at McMaster University.

23 Dec 2011

Science journal names UNC HIV prevention study as 2011 Breakthrough of the Year

The HIV Prevention Trials Network 052 study, led by Myron S. Cohen, MD of the University of North Carolina at Chapel Hill, has been named the 2011 Breakthrough of the Year by the journal Science.

23 Dec 2011

Report: Funding cuts put public health preparedness at risk

Trust for America's Health and the Robert Wood Johnson Foundation concluded the nation's public health capacity is being undermined by funding cuts to state and local health departments.

22 Dec 2011

Researchers map every apparent physical interaction of HIV virus with human cells

In perhaps the most comprehensive survey of the inner workings of HIV, an international team of scientists led by researchers at the University of California, San Francisco has mapped every apparent physical interaction the virus makes with components of the human cells it infects—work that may reveal new ways to design future HIV/AIDS drugs.

22 Dec 2011

Researchers evaluate Clade C HIV envelope protein in Phase I trial

In the first clinical trial of an injectable vaccine containing trimeric HIV envelope protein (gp140) relevant to the predominant strain of HIV in Africa, researchers from four UK academic centers (St George's University London, Imperial College, Hull York Medical School (HYMS; University of York) and the Medical Research Council Clinical Trial Unit) and from the Infectious Disease Research Institute (IDRI) have come together to evaluate whether the vaccine is safe for use in human volunteers.

22 Dec 2011

Virus with potential for bioterrorism created – Experts worried

Two major scientific journals are debating on whether to publish details of a man-made mutant flu virus that could kill billions, after a US government's science advisory committee advised them to withhold key details.

21 Dec 2011

Research into how flying fox spreads infectious diseases

The flying fox is an adorable doe-eyed bat with a dark side - it is the perfect vector for emerging infectious diseases from Asia. Susan Tsang, a PhD student in ecology and evolutionary biology at The City College of New York and the CUNY Graduate Center, turned to a revolutionary way to help fund her research into how this species spreads disease.

21 Dec 2011

'Money well spent today means less money spent tomorrow' on HIV/AIDS

This Lancet Infectious Diseases editorial responds to the Global HIV/AIDS Response 2011 progress report (.pdf) launched by WHO, UNICEF, and UNAIDS on November 30, writing that the report "contains much good news on treatment and prevention, but the gains made by past efforts are jeopardized by the ongoing global financial crisis and dwindling funds."

21 Dec 2011

SMA honors JSUMC obstetrician with Robert D. and Alma W. Moreton Original Research Award

Jersey Shore University Medical Center is pleased to announce that Mark G. Martens, M.D. chairman of Department of Obstetrics and Gynecology, was honored in November by the Southern Medical Association (SMA) with the Robert D. and Alma W. Moreton Original Research Award.

21 Dec 2011

Vacc-4x nasal vaccine can effectively treat HIV

Thirty years after AIDS was first described, there is still no effective vaccine against the HIV virus. Worldwide, roughly 33 million people are HIV-positive. Researchers are working to find out whether a HIV vaccine developed by a Norwegian biotech company can be administered nasally.

21 Dec 2011

MacroGenics to receive milestone payment from Boehringer Ingelheim

MacroGenics, Inc., a privately held biotechnology company that develops next generation antibody therapeutics, announced today that it will receive a milestone payment from Boehringer Ingelheim.

20 Dec 2011

Three-dose artesunate therapy effective in treating children with malaria

A shorter anti-malaria treatment is as effective in treating seriously ill children as the standard regimen, according to new research. Researchers have shown that three doses over two days of the drug artesunate are as effective in killing the malaria parasite in the blood as five doses over three days.

20 Dec 2011

OneWorld Health to become PATH affiliate

"PATH and OneWorld Health (OWH) on Friday announced that OWH will become an affiliate of PATH, bringing its drug development expertise and experience in neglected infectious diseases to bear on PATH's mission of improving global health through innovation," according to a PATH press release.

20 Dec 2011

New gel could nip Lyme borreliosis infection in the bud

They come out in the spring, and each year they spread further - the ticks. Thirty percent of them transmit borrelia pathogens, the causative agent of Lyme borreliosis that can damage joints and organs.

19 Dec 2011

Scientists discover a way to keep normal and cancer cells alive in the lab

In a major step that could revolutionize biomedical research, scientists have discovered a way to keep normal cells as well as tumor cells taken from an individual cancer patient alive in the laboratory - which previously had not been possible. Normal cells usually die in the lab after dividing only a few times, and many common cancers will not grow, unaltered, outside of the body.

19 Dec 2011

President Obama honors mentoring program for minority girls in science and health

Teresa Woodruff, the Thomas J. Watkins Professor of Obstetrics and Gynecology at Northwestern University Feinberg School of Medicine, received the prestigious Presidential Award for Excellence in Science, Mathematics and Engineering Mentoring at the White House from President Barack Obama Monday, Dec. 12.

17 Dec 2011

Immediate ART appears preferable to deferring treatment among recently infected HIV patients

Among people recently infected with HIV, immediate antiretroviral therapy (ART) appears preferable to deferring treatment, according to a new study published in The Journal of Infectious Diseases and now available online.

17 Dec 2011

Soligenix secures Harvard option rights to initiate anthrax vaccine development program

Soligenix, Inc., a development stage biopharmaceutical company, announced today that it has initiated a next generation anthrax vaccine development program pursuant to a field-exclusive option agreement with Harvard University to negotiate a license under patent rights that cover prophylactic uses of a modified anthrax toxin protein.

16 Dec 2011